Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05293912
Title SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hangzhou Sumgen Biotech Co., Ltd.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Northside Hospital Recruiting Atlanta Georgia 30342 United States Details
John Theurer Cancer Center at Hackensack UMC Recruiting Hackensack New Jersey 07601 United States Details
Westchester Medical Center Not yet recruiting Hawthorne New York 10532 United States Details
Novant Health Forsyth Medical Center Recruiting Charlotte North Carolina 27103 United States Details
Duke University Not yet recruiting Durham North Carolina 27705 United States Details
Novant Health Cancer Institute Hematology - Forsyth Recruiting Winston-Salem North Carolina 27103 United States Details
Gabrail Cancer Center Research, LLC Recruiting Canton Ohio 44718 United States Details
Texas Oncology / Baylor Charles A. Sammons Cancer Center Not yet recruiting Dallas Texas 75246 United States Details
*Shaded cells indicate that there was no data available from for the field